Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm Secures Series E Financing

NEW YORK, June 27 (GenomeWeb News) - Fluidigm announced today it has secured series E funding from AllianceBernstein.


The company plans to use the money to develop and commercialize new applications for its proprietary integrated fluidic circuits technology, which has applications in genomics and proteomics.


Fluidigm's BioMark system uses IFCs for genetic and protein analysis, and the company said that it is developing further IFC-based systems "for rapid synthesis of radio-labeled imaging probes and preparation of nucleic acids for analysis."


Fluidigm declined to disclose the amount of the funding.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.